Helius Medical Technologies, Inc. (HSDT)
- Previous Close
5.16 - Open
5.15 - Bid 4.96 x 100
- Ask 5.28 x 100
- Day's Range
5.10 - 5.16 - 52 Week Range
4.29 - 14.45 - Volume
6,594 - Avg. Volume
411,619 - Market Cap (intraday)
4.534M - Beta (5Y Monthly) 1.55
- PE Ratio (TTM)
-- - EPS (TTM)
-14.56 - Earnings Date May 9, 2024 - May 13, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
15.47
Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company was incorporated in 2014 and is headquartered in Newtown, Pennsylvania.
heliusmedical.comRecent News: HSDT
Performance Overview: HSDT
Trailing total returns as of 4/18/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: HSDT
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: HSDT
Valuation Measures
Market Cap
4.53M
Enterprise Value
-590.92k
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
4.82
Price/Book (mrq)
1.93
Enterprise Value/Revenue
-0.92
Enterprise Value/EBITDA
0.05
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-61.40%
Return on Equity (ttm)
-168.55%
Revenue (ttm)
644k
Net Income Avi to Common (ttm)
-8.85M
Diluted EPS (ttm)
-14.56
Balance Sheet and Cash Flow
Total Cash (mrq)
5.18M
Total Debt/Equity (mrq)
2.43%
Levered Free Cash Flow (ttm)
-6.11M